{{Rsnum
|rsid=7517566
|Gene=ARNT
|Chromosome=1
|position=150877559
|Orientation=plus
|GMAF=0.1175
|Gene_s=ARNT
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 15.9 | 84.1
| HCB | 8.0 | 32.1 | 59.9
| JPT | 0.9 | 24.8 | 74.3
| YRI | 3.4 | 15.6 | 81.0
| ASW | 0.0 | 26.3 | 73.7
| CHB | 8.0 | 32.1 | 59.9
| CHD | 4.6 | 36.7 | 58.7
| GIH | 2.0 | 16.8 | 81.2
| LWK | 1.8 | 26.4 | 71.8
| MEX | 0.0 | 12.1 | 87.9
| MKK | 3.2 | 34.0 | 62.8
| TSI | 0.0 | 16.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23168330
|Title=Genetic susceptibility to dioxin-like chemicals' induction of cytochrome P4501A2 in the human adult linked to specific AhRR polymorphism
}}

{{PMID Auto
|PMID=18366646
|Title=Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: Mutation detection, case-control studies, and gene expression analysis.
|OA=1
}}

{{PMID Auto
|PMID=18632753
|Title=Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}